Showing results (1651-1660 of 1,768) with videos related to

Sort By:
Pageof 177
The AAPS Journal|December 16, 2005
Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applicationsVenkatesh A Bhattaram, Brian P Booth, Roshni P Ramchandani, et al.
The American Journal of Tropical Medicine and Hygiene|July 8, 2015
Safety and Immunogenicity of a Dengue Virus Serotype-1 Purified-Inactivated Vaccine: Results of a Phase 1 Clinical TrialLuis Javier Martinez, Leyi Lin, Jason M Blaylock, et al.
Journal of Medical Genetics|July 22, 2005
Congenital hyperinsulinism and mosaic abnormalities of the ploidyI Giurgea, D Sanlaville, J-C Fournet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2014
The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1J Chris Kingswood, Sergiusz Jozwiak, Elena D Belousova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2022
Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast CancerParvin F Peddi, Peter A Fasching, Duan Liu, et al.
Cancer Treatment Reviews|February 1, 2008
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxelMinetta C Liu, George D Demetri, Donald A Berry, et al.
JAMA|August 10, 2002
Sertraline treatment of major depression in patients with acute MI or unstable anginaAlexander H Glassman, Christopher M O'Connor, Robert M Califf, et al.
Journal of Medicinal Chemistry|December 21, 2013
Substituted 2-phenylimidazopyridines: a new class of drug leads for human African trypanosomiasisHari Babu Tatipaka, J Robert Gillespie, Arnab K Chatterjee, et al.
Journal of the Advanced Practitioner in Oncology|January 13, 2025
Impact of an Oncology Clinical Pharmacist Intervention on Clinical Trial Enrollment in The US Oncology Network's MYLUNG ConsortiumElizabeth Koselke, Lisa C Kaspin-Powell, Shannon Hough, et al.
The Oncologist|July 2, 2013
Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, HER2-positive early breast cancer: results from the BCIRG 006 StudyHeather-Jane Au, Wolfgang Eiermann, Nicholas J Robert, et al.
Pageof 177